Ultra-high field NMR device adds to understanding of drug resistance Scientists at St. Jude used the most powerful NMR device in the United States to study a protein that drives some leukemias. Building bridges: PARP enzymes bring broken DNA together St. Jude researchers capture the structure of PARP enzymes at work, leading to a new understanding of DNA repair that may aid cancer treatments targeting the process. Computational tool helps to illuminate hidden mutations St. Jude researchers developed a powerful tool that can identify cancer-causing mutations in genomes. St. Jude recognized as clinical care center for rare von Hippel-Lindau syndrome St. Jude is the first and only VHL Alliance-recognized Clinical Care Center dedicated solely to children. St. Jude Children’s Research Hospital Graduate School of Biomedical Sciences adds Master of Science in Clinical Investigations New program looking to attract professionals or students interested in clinical research From Promise, Special Edition 2020 Donate Now Promise Archive First name: Last name: Email: Message: Submit Feedback Thank you for your feedback! More articles from this issue Your Body, Your Genes, Our Future Pediatric Cancer Genome Project explores DNA, genome sequencing, and their relationship to cancer. The Spark that Ignites Innovation The architect of the Pediatric Cancer Genome Project reflects on the initiative’s origins and legacy. Biorepository is ‘Library’ of the Pediatric Cancer Genome Project The St. Jude Biorepository collects and stores biomedical samples, allowing scientists to explore the origins of pediatric cancer and develop new diagnostic tests and therapies. Pediatric Cancer Genome Project Impacts Patient Care The Pediatric Cancer Genome Project has changed the landscape of how pediatric cancer patients are diagnosed and treated at St. Jude. Cancer Predisposition: Power through the PCGP As a result of the Pediatric Cancer Genome Project, families facing an increased risk of inherited cancers can turn to the St. Jude Cancer Predisposition Program. The Pediatric Cancer Genome Project: Era of Discovery In 2010, St. Jude embarked on the world’s most ambitious effort to discover the origins of childhood cancer and seek new cures. Here’s how that historic project has unfolded. Crystal Ball: The Legacy of the PCGP What will be the legacy of the Pediatric Cancer Genome Project? Several scientists offer predictions. 100 Trillion Reasons to Love St. Jude The Pediatric Cancer Genome Project has produced more than 100 trillion pieces of data, freely accessible by scientists around the world. Life after St. Jude: Dakota’s Dreams This young survivor's treatment was made possible in part by the Pediatric Cancer Genome Project.